InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Browse the complete record of transactions filed by Olson Eric R, Directeur Scientifique. Officer active across 1 companies, notably Syros Pharmaceuticals, Inc.. Aggregated, 5 reports have been logged. Total volume traded: €24k. The latest transaction was disclosed on 1 April 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is free.
Declarations5 total
€27,58027,266 shares@ €1.011553.0% of flow
Common Stock
SEC:0001209191-22-022503:0·
€6,7842,208 shares@ €3.072555.4% of flow
Common Stock
SEC:0001209191-22-002216·
€6,7842,208 shares@ €3.072513.0% of flow
Common Stock
SEC:0001209191-22-002216:0·
€5,4531,164 shares@ €4.68544.6% of flow
Common Stock
SEC:0001209191-21-044493·
€5,4531,164 shares@ €4.68510.5% of flow
Common Stock
SEC:0001209191-21-044493:0·
5 of 5 declarations
About Olson Eric R
Eric R. Olson is the Chief Scientific Officer at Syros Pharmaceuticals, Inc. He is responsible for leading the company's research and development efforts. With a strong background in the pharmaceutical field, he plays a key role in innovation and the discovery of new treatments. Syros Pharmaceuticals focuses on developing targeted therapies for genetic diseases and cancer.
